Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

671 public trials 177 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Completed

A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer

NCT00399789

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • AOI Pharmaceuticals Investigative Site Tucson, Arizona, United States
  • AOI Pharmaceuticals Investigative Site Pomona, California, United States
  • AOI Pharmaceuticals Investigative Site Aventura, Florida, United States
  • AOI Pharmaceuticals Investigative Site Hollywood, Florida, United States
View all 21 locations
View Trial Details
Completed

Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy

NCT00364351

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Berkeley, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Boynton Beach, Florida, United States
View all 153 locations
View Trial Details
Completed

The Value of Surgical Mediastinal Staging in Clinical N1 Lung Cancer

NCT02222194

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University Hospital Leuven Leuven, Belgium
  • Aix-Marseille University & Hospitals System of Marseille (AP-HM) Marseille, France
  • ELK Berlin Chest Hospital Berlin, Germany
  • Albert-Ludwigs-University Freiburg Freiburg im Breisgau, Germany
View Trial Details
Completed

Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer

NCT01951690

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Colorado Cancer Center, Anschutz Medical Campus Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT01390818

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +37 more
Locations
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions